(The Center Square) – The U.S. House could soon vote on resolutions seeking to end President Donald Trump's tariffs around the globe.
(The Center Square) – With the deadline to fund the Department of Homeland Security only days away, Democrats have refused an offer from the White House to strike a compromise over Immigrations and Customs Enforcement changes.
Editor's note: This story has been updated since its original publication.
(The Center Square) – The U.S. House Oversight Committee is investigating claims of noncitizen voting in Michigan.
(The Center Square) - Even as states across the country introduce and pass legislation to reshape congressional districts to favor one political party over another, several states that have not enacted mid-decade redistricting expect fierce congressional races.
(The Center Square) – After concerns were raised about spending on DEI, the University of Wisconsin-Madison shuttered a department but kept most of the staff and their titles working on equity issues, an investigation by The Center Square found.
(The Center Square) – The U.S. House passed a critical government funding package along bipartisan lines in a nail-biter Tuesday vote, sending it to the president’s desk.
(The Center Square) – To the dismay of her critics, U.S. Rep. Nancy Pelosi has made millions from Wall Street while in Congress, but the California Democrat is not alone. U.S. Rep. Josh Gottheimer, a New Jersey Democrat, has also made a fortune, pursuing an aggressive and sophisticated investment strategy similar to Pelosi's. It is one that may have benefited from a perch on Capitol Hill, a family member with venture capital expertise, and extensive use of a financial tool known as call options, an investigation by The Center Square found.
(The Center Square) – As the federal government enters its third day of a partial shutdown, House Republicans are bickering over Senate changes to the $1.2 trillion funding package, jeopardizing the upcoming vote.
(The Center Square) – Illinois lawmakers are pushing an amendment to ban restrictions or interference with a federal discount drug program.
